NEW YORK (GenomeWeb News) – UK cancer biomarker firm Abcodia today announced a collaboration with the Austrian Institute of Technology to validate biomarkers for the early detection of lung and colorectal cancers.

Accessing a longitudinal collection of serum samples derived from a population cohort involved in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), Abcodia and AIT will design longitudinal studies to validate panels of biomarkers.

UKCTOCS is a randomized controlled trial for assessing the effect of screening on mortality.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.